These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1942288)

  • 1. Effects of pinacidil on detrusor instability in men with bladder outlet obstruction.
    Hedlund H; Mattiasson A; Andersson KE
    J Urol; 1991 Nov; 146(5):1345-7. PubMed ID: 1942288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urodynamics and safety of the β₃-adrenoceptor agonist mirabegron in males with lower urinary tract symptoms and bladder outlet obstruction.
    Nitti VW; Rosenberg S; Mitcheson DH; He W; Fakhoury A; Martin NE
    J Urol; 2013 Oct; 190(4):1320-7. PubMed ID: 23727415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urodynamic effects of finasteride in the treatment of bladder outlet obstruction due to benign prostatic hyperplasia.
    Tammela TL; Kontturi MJ
    J Urol; 1993 Feb; 149(2):342-4. PubMed ID: 7678871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind comparator trials with pinacidil, a potassium channel opener.
    Callaghan JT; Goldberg MR; Brunelle R
    Drugs; 1988; 36 Suppl 7():77-82. PubMed ID: 3076139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination treatment with an alpha-blocker plus an anticholinergic for bladder outlet obstruction: a prospective, randomized, controlled study.
    Athanasopoulos A; Gyftopoulos K; Giannitsas K; Fisfis J; Perimenis P; Barbalias G
    J Urol; 2003 Jun; 169(6):2253-6. PubMed ID: 12771763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of pinacidil on bladder muscle.
    Andersson KE; Andersson PO; Fovaeus M; Hedlund H; Malmgren A; Sjögren C
    Drugs; 1988; 36 Suppl 7():41-9. PubMed ID: 3076135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and urodynamic effects of baclofen in women with functional bladder outlet obstruction: Preliminary report.
    Chen CH; Hsiao SM; Chang TC; Wu WY; Lin HH
    J Obstet Gynaecol Res; 2016 May; 42(5):560-5. PubMed ID: 27108667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detrusor instability in men: correlation of lower urinary tract symptoms with urodynamic findings.
    Hyman MJ; Groutz A; Blaivas JG
    J Urol; 2001 Aug; 166(2):550-2; discussion 553. PubMed ID: 11458066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The action of pinacidil in the isolated human bladder.
    Fovaeus M; Andersson KE; Hedlund H
    J Urol; 1989 Mar; 141(3):637-40. PubMed ID: 2918608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detrusor contraction duration as a urodynamic parameter of bladder outlet obstruction for evaluating men with lower urinary tract symptoms.
    Ameda K; Steele GS; Sullivan MP; Stember D; Yalla SV
    J Urol; 1998 Aug; 160(2):482-6. PubMed ID: 9679903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normal insulin release during sustained hyperglycaemia in hypokalaemic periodic paralysis: role of the potassium channel opener pinacidil in impaired muscle strength.
    Ligtenberg JJ; Van Haeften TW; Van Der Kolk LE; Smit AJ; Sluiter WJ; Reitsma WD; Links TP
    Clin Sci (Lond); 1996 Nov; 91(5):583-9. PubMed ID: 8942397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An observational urodynamic evaluation of men with lower urinary tract symptoms treated with doxazosin.
    Gerber GS; Kim JH; Contreras BA; Steinberg GD; Rukstalis DB
    Urology; 1996 Jun; 47(6):840-4. PubMed ID: 8677574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urodynamic risk factors for renal dysfunction in men with obstructive and nonobstructive voiding dysfunction.
    Comiter CV; Sullivan MP; Schacterle RS; Cohen LH; Valla SV
    J Urol; 1997 Jul; 158(1):181-5. PubMed ID: 9186351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of pinacidil and cromakalim (BRL 34915) on bladder function in rats with detrusor instability.
    Malmgren A; Andersson KE; Sjögren C; Andersson PO
    J Urol; 1989 Oct; 142(4):1134-8. PubMed ID: 2795743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of terazosin on functional bladder outlet obstruction in women: a pilot study.
    Kessler TM; Studer UE; Burkhard FC
    J Urol; 2006 Oct; 176(4 Pt 1):1487-92. PubMed ID: 16952666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosing bladder outlet obstruction in women.
    Nitti VW; Tu LM; Gitlin J
    J Urol; 1999 May; 161(5):1535-40. PubMed ID: 10210391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solifenacin plus tamsulosin combination treatment in men with lower urinary tract symptoms and bladder outlet obstruction: a randomized controlled trial.
    Kaplan SA; He W; Koltun WD; Cummings J; Schneider T; Fakhoury A
    Eur Urol; 2013 Jan; 63(1):158-65. PubMed ID: 22831853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detrusor contractility and compliance characteristics in adult male patients with obstructive and nonobstructive voiding dysfunction.
    Sullivan MP; Yalla SV
    J Urol; 1996 Jun; 155(6):1995-2000. PubMed ID: 8618307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urodynamic findings in women with refractory overactive bladder symptoms.
    Al-Zahrani AA; Gajewski J
    Int J Urol; 2016 Jan; 23(1):75-9. PubMed ID: 26417863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Video-urodynamic characteristics of non-neurogenic, idiopathic underactive bladder in men - A comparison of men with normal tracing and bladder outlet obstruction.
    Jiang YH; Kuo HC
    PLoS One; 2017; 12(4):e0174593. PubMed ID: 28376105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.